Skip to main content
    T

    Tandem Diabetes Care Inc (TNDM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $17.06
    -1.42 (-7.68%)

    Market Cap: $1.40B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Tandem Diabetes Care Inc (TNDM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tandem Diabetes Care (TNDM) has a market cap of $1.40B and an enterprise value of $1.93B. It earned -$49.23M on revenue of $1.08B over the last 12 months.

    Total Valuation

    Enterprise value is 37.88% above the market cap, as debt exceeds cash.

    Market Cap$1.40B
    Enterprise Value$1.93B
    Latest price (Nov 17, 2026)$17.06

    Key Dates

    The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 17, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.93% in the quarter ended Sep 30, 2026 and grew 3.09% a year over 2 years.

    Shares Outstanding69.65M
    Shares Change (YoY)+2.95%
    Shares Change (QoQ)+0.93%
    Share Count Growth (2Y CAGR)+3.09%

    Valuation Ratios

    Sales and book value multiples are 1.1x and 8.8x. Its year-end P/S ranged from 0.1x to 13.6x from 2016 to 2025.

    P/S Ratio1.1x
    Forward P/S1.3x
    P/B Ratio8.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 8.33% over 52 weeks and trades 1.44% below its 50-day average.

    Beta (1Y)1.19
    52-Week Change-8.33%
    1-Month Change+4.15%
    3-Month Change-27.28%
    6-Month Change+23.09%
    5-Year Change-85.98%
    10-Year Change-68.41%
    Total Return (1Y)-8.33%
    Total Return (3Y CAGR)-1.39%
    Total Return (5Y CAGR)-34.09%
    Return vs SPY (1Y)-20.38%
    Max Drawdown (1Y)-54.64%
    Max Drawdown (3Y)-81.07%
    Sharpe Ratio (1Y)-0.13
    Correlation with SPY (1Y)0.22
    50-Day Average$17.31
    200-Day Average$18.82
    52-Week Range$12.26 to $29.65
    RSI (14 Days)45.9
    Average Volume (20 Days)2.83M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.21x current liabilities, and total debt is 4.47x shareholder equity.

    Current Ratio3.21x
    Quick Ratio2.65x
    Debt / Equity4.47x
    Interest Coverage-2.80x

    Returns and Efficiency

    Return on invested capital is -3.43% over the last 12 months, against a 5-year average of -31.80%.

    Return on Equity (ROE)-36.45%
    Return on Assets (ROA)-4.25%
    Return on Invested Capital (ROIC)-3.43%
    Return on Capital Employed (ROCE)-2.80%
    ROE (5Y Average)-51.46%
    ROA (5Y Average)-12.76%
    ROIC (5Y Average)-31.80%
    Asset Turnover1.06x
    Inventory Turnover3.35x
    Receivables Turnover6.29x
    Cash Conversion Cycle113 days

    Scores

    TNDM has an Altman Z-Score of 0.57, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score0.57
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.08B over the last 12 months is up 6.84% from the 12 months before.

    Revenue$1.08B
    Revenue Growth (YoY)+6.84%
    Gross Profit$609.45M
    Operating Income-$25.30M
    Pretax Income-$43.55M
    Net Income-$49.23M
    EBITDA-$9.17M
    EBIT-$25.30M
    Reported EPS (TTM)-$0.72

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 11.65% of the $1.16B in total assets.

    Cash and Equivalents$72.84M
    Total Debt$603.39M
    Net Debt$530.55M
    Net Debt Per Share$7.62
    Working Capital$564.65M
    Shareholder Equity$135.09M
    Book Value Per Share$1.94
    Total Assets$1.16B
    Total Liabilities$1.02B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $21.69M of capital spending, operating cash flow left -$36.30M of free cash flow.

    Operating Cash Flow-$14.61M
    Capital Expenditures$21.69M
    Free Cash Flow-$36.30M
    FCF Per Share-$0.52
    Depreciation and Amortization$19.83M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -2.35%, against a 5-year average of -13.71%.

    Gross Margin56.65%
    Operating Margin-2.35%
    Pretax Margin-4.05%
    Net Margin-4.58%
    EBITDA Margin-0.85%
    EBIT Margin-2.35%
    FCF Margin-3.37%
    Gross Margin (5Y Average)52.03%
    Operating Margin (5Y Average)-13.71%
    Net Margin (5Y Average)-13.95%

    Growth

    Revenue grew 8.19% a year over 3 years.

    Revenue Growth (3Y CAGR)+8.19%
    Revenue Growth (5Y CAGR)+15.26%
    Book Value Per Share Growth (2Y CAGR)-31.04%
    Tangible Book Per Share Growth (2Y CAGR)-31.04%

    Revenue and profit by year

    Dividends and Yields

    TNDM does not pay a dividend. Its free cash flow yield is -3.05%.

    FCF Yield-3.05%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Oct 10, 2017.

    Last Split DateOct 10, 2017
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 12 similar companies, TNDM has the 10th highest P/S.

    P/S Ratio1.1x vs 3.3x median
    ROIC-3.43% vs -16.70% median
    Revenue Growth (Trailing 4 Quarters, YoY)+6.84% vs +13.46% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 6.77% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+6.77%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About TNDM

    What is TNDM's market cap?

    Tandem Diabetes Care has a market cap of $1.40B. Its enterprise value, which adds debt and subtracts cash, is $1.93B.

    How many shares of TNDM are outstanding?

    Tandem Diabetes Care has 69.65M shares outstanding. The count is up 2.95% from a year earlier.

    Does TNDM pay a dividend?

    No. Tandem Diabetes Care does not pay a dividend.

    How much debt does TNDM have?

    Tandem Diabetes Care has $603.39M of total debt and $72.84M of cash and equivalents, a net debt position of $530.55M.